CIBC Private Wealth Group
BIVV

CIBC Private Wealth Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

CIBC Private Wealth Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,437
Closed -$131K – 2170
2017
Q4 		$131K Buy
+2,437
New +$133K ﹤0.01% 994

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

CIBC Private Wealth Group's BIVV Position: Q1 2018 in Review

CIBC Private Wealth Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 2,437 shares — an estimated $131K sold.

CIBC Private Wealth Group first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $131K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • CIBC Private Wealth Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 2,437 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $131K.
  • CIBC Private Wealth Group first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • CIBC Private Wealth Group's Bioverativ Inc. Common Stock position peaked at $131K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on CIBC Private Wealth Group's 13F filing for Q1 2018, filed 17 May 2018.